Increased serum YKL-40 in patients with pulmonary sarcoidosis - A potential marker of disease activity?

Respiratory Medicine

Volumn 99, Issue 4, 2005, Pages 396-402

  Johansen, Julia S ^a,d   Milman, Nils ^a   Hansen, Michael ^a   Garbarsch, Charly ^b   Price, Paul A ^c   Graudal, Niels ^a,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

39 kDa heparin binding protein; CHI3L1; Giant cells; Pulmonary fibrosis; Pulmonary sarcoidosis; YKL 40

Indexed keywords

CARBON MONOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE; GROWTH FACTOR; PREDNISOLONE; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG SARCOIDOSIS; LUNG VOLUME; MACROPHAGE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY;

ADULT; BIOLOGICAL MARKERS; FEMALE; GIANT CELLS; GLYCOPROTEINS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; STATISTICS, NONPARAMETRIC;

EID: 14844284556     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.09.016     Document Type: Article

References (49)

1. B.E. Hakala C. White A.D. Recklies Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family J Biol Chem 268 1993 25803-25810
2. J.S. Johansen H.S. Jensen P.A. Price A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid Br J Rheumatol 32 1993 949-955
3. B. Hu K. Trinh W.F. Figueira P.A. Price Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family J Biol Chem 271 1996 19415-19420
4. L.M. Shackelton D.M. Mann A.J.T. Millis Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodelling J Biol Chem 270 1995 13076-13083
5. G.H. Renkema R.G. Boot F.L. Au W.E. Donker-Koopman et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages Eur J Biochem 251 1998 504-509
6. M. Rehli S.W. Krause R. Andreesen Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation Genomics 43 1997 221-225
7. D.R. Houston A.D. Recklies J.C. Krupa D.M.F. van Aalten Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes J Biol Chem 278 2003 30206-30212
8. A.D. Recklies C. White H. Ling The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways Biochem J 365 2002 119-126
9. F. De Ceuninck S. Gaufillier A. Bonnaud M. Sabatini C. Lesur P. Pastoureau YKL-40 (Cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes Biochem Biophys Res Commun 285 2001 926-931
10. K.M. Malinda L. Ponce H.K. Kleinman L.M. Shackelton A.J.T. Millis Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells Exp Cell Res 250 1999 168-173
11. B. Volck P.A. Price J.S. Johansen et al. YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils Proc Assoc Am Phys 110 1998 351-360
12. S.W. Krause M. Rehli M. Kreutz L. Schwarzfischer J.D. Paulauskis R. Andreesen Differential screening identifies genetic markers of monocyte to macrophage maturation J Leukoc Biol 60 1996 540-545
13. R.B. Kirkpatrick J.G. Emery J.R. Connor R. Dodds P.G. Lysko M. Rosenberg Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages Exp Cell Res 237 1997 46-54
14. J.S. Johansen M.K. Williamson J.S. Rice P.A. Price Identification of proteins secreted by human osteoblastic cells in culture J Bone Miner Res 7 1992 501-512
15. B.W. Morrison P. Leder neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors Oncogene 9 1994 3417-3426
16. D. Baeten A.M.H. Boots P.G.A. Steenbakkers et al. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium Correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 43 2000 1233-1243
17. B. Volck J.S. Johansen M. Stoltenberg et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology Osteoarthritis Cartilage 9 2001 203-214
18. R.G. Boot T.A.E. van Achterberg B.E. van Aken et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages Arterioscler Thromb Vasc Biol 19 1999 687-694
19. J.S. Johansen B. Baslund Garbarsch et al. YKL-40 in giant cells and macrophages from patients with giant cell arteritis Arthritis Rheum 42 1999 2624-2630
20. S. Harvey M. Weisman J. O'Dell et al. Chondrex: New marker of joint disease Clin Chem 44 1998 509-516
21. J.S. Johansen M. Stoltenberg M. Hansen et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity Rheumatology 38 1999 618-626
22. I.C. Koutroubakis E. Petinaki P. Dimoulios et al. Increased serum levels of YKL-40 in patients with inflammatory bowel disease Int J Colorectal Dis 18 2003 254-259
23. I. Vind J.S. Johansen P.A. Price P. Munkholm Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease Scand J Gastroenterol 38 2003 599-605
24. C. Nordenbaek J.S. Johansen P. Junker N. Borregaard O. Sørensen P.A. Price YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization J Infect Dis 180 1999 1722-1726
25. G. Kronborg C. Østergaard N. Weis et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated to the outcome of the disease Scand J Infect Dis 34 2002 323-326
26. J.S. Johansen P. Christoffersen S. Møller et al. Serum YKL-40 is increased in patients with hepatic fibrosis J Hepatol 32 2000 911-920
27. A. Tran S. Benzaken M-C. Saint-Paul et al. Chondrex (YKL-40), a potential new serum fibrosis maker in patients with alcoholic liver disease Eur J Gastroenterol Hepatol 12 2000 989-993
28. Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U and the EMALD Group. Serum YKL-40 and PIIINP levels as prognostic markers in patients with alcoholic liver disease. J Hepatol 2003;39:179-86
29. C. Cintin J.S. Johansen I.J. Christensen P.A. Price S. Sørensen H.J. Nielsen Serum YKL-40 and colorectal cancer Br J Cancer 79 1999 1494-1499
30. M.K. Tanwar M.R. Gilbert E.C. Holland Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma Cancer Res 62 2002 4364-4368
31. B.V. Jensen J.S. Johansen P.A. Price High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer Clin Cancer Res 9 2003 4423-4434
32. E.V.S. Høgdall J.S. Johansen S.K. Kjaer et al. High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival Oncol Rep 10 2003 1535-1538
33. L.S. Newman C.S. Rose L.A. Maier Sarcoidosis N Engl J Med 336 1997 1224-1234
34. N. Milman O. Selroos Pulmonary sarcoidosis in the Nordic countries 1950-1982 Epidemiology and clinical picture. Sarcoidosis 7 1990 50-57
35. N. Milman O. Selroos Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis Sarcoidosis 7 1990 113-118
36. R.K.A. Allen Fao. Mendelsohn J. Csicsmann et al. A clinical evaluation of serum angiotensin-converting enzyme in sarcoidosis Aust NZ J Med 10 1980 496-501
37. J. Lieberman L.A. Schlessner A. Nosal A. Sastre F.S. Mishkin Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, gallium-67 scans, chest roentgenograms and pulmonary function Chest 84 1983 522-528
38. R.K.A. Allen A review of angiotensin-converting enzyme in health and disease Sarcoidosis 8 1991 95-100
39. R.K.A. Allen S.Y. Chai M.S. Dunbar F.A.O. Mendelsohn In vitro autoradiographic localisation of angiotensin-converting enzyme in sarcoid lymph nodes Chest 90 1986 315-320
40. F.K. Romer Clinical and biochemical aspects of sarcoidosis with special reference to angiotensin-converting enzyme (ACE) Acta Med Scand 690 suppl 1984 1-96
41. J.S. Johansen J. Hvolris M. Hansen V. Backer I. Lorenzen P.A. Price Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint Br J Rheumatol 35 1996 553-559
42. H.M. Neels S.L. Sharpe M.E. van Sande G.A. Fonteyne Single reagent microcentrifugal assay for angiotensin converting enzyme in serum Clin Chem 30 1984 163-164
43. G.F.M. Verheijden A.W.M. Rijnders E. Bos et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis Arthritis Rheum 40 1997 1115-1125
44. L.A.B. Joosten C.J.J. Coenen-de Roo M.M.A. Helsen et al. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/ 1 mice Arthritis Rheum 43 2000 645-655
45. K. Vos A.M.M. Miltenburg K.E. van Meijgaarden et al. Cellular immune response to human cartilage glycoprotein-39 (HC-gp)-derived peptides in rheumatoid arthtitis and other inflammatory conditions Rheumatology 39 2000 1326-1331
46. H.W.L. Ziegler-Heitbrock Heterogeneity of human blood monocytes: The CD14+CD16+ subpopulation Immunol Today 17 1996 424-428
47. G. Fingerle A. Pforte B. Passlick M. Blumenstein M. Ströbel H.W.L. Ziegler-Heitbrock The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients Blood 82 1993 3170-3176
48. G. Vanham K. Edmonds L. Qing et al. Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV infection Clin Exp Immunol 103 1996 30-34
49. M.N. Saleh S.J. Goldman A.F. LoBuglio et al. CD16+ monocytes in patients with cancer: Spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor Blood 85 1995 2910-2991